Wendell David Associates Inc Danaher Corp Transaction History

Wendell David Associates Inc

$1.05 Billion
Q3 2024

A detailed history of Wendell David Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Wendell David Associates Inc holds 74,363 shares of DHR stock, worth $17.5 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares

74,363

Previous 75,753 1.83%

Holding current value

$17.5 Million

Previous $18.9 Million 9.24%

% of portfolio

1.98%

Previous 1.93%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$239.25 - $280.76 $332,557 - $390,256	-1,390 Reduced 1.83%	74,363 $20.7 Million
Q2 2024 Jul 22, 2024	BUY	$235.51 - $267.98 $5,887 - $6,699	25 Added 0.03%	75,753 $18.9 Million
Q1 2024 Apr 22, 2024	SELL	$224.58 - $256.19 $236,707 - $270,024	-1,054 Reduced 1.37%	75,728 $18.9 Million
Q4 2023 Jan 22, 2024	BUY	$185.1 - $233.13 $74,965 - $94,417	405 Added 0.53%	76,782 $17.8 Million
Q3 2023 Oct 20, 2023	SELL	$233.08 - $265.59 $238,907 - $272,229	-1,025 Reduced 1.32%	76,377 $18.9 Million
Q2 2023 Jul 20, 2023	SELL	$224.99 - $256.14 $216,890 - $246,918	-964 Reduced 1.23%	77,402 $18.6 Million
Q1 2023 Apr 19, 2023	BUY	$239.75 - $277.0 $111,483 - $128,805	465 Added 0.6%	78,366 $19.8 Million
Q4 2022 Jan 17, 2023	SELL	$241.42 - $282.29 $188,307 - $220,186	-780 Reduced 0.99%	77,901 $20.7 Million
Q3 2022 Oct 18, 2022	SELL	$247.06 - $1507.4 $8,647 - $52,759	-35 Reduced 0.04%	78,681 $20.3 Million
Q2 2022 Jul 14, 2022	SELL	$237.11 - $299.66 $262,717 - $332,023	-1,108 Reduced 1.39%	78,716 $20 Million
Q1 2022 Apr 22, 2022	SELL	$257.27 - $315.76 $115,771 - $142,092	-450 Reduced 0.56%	79,824 $23.4 Million
Q4 2021 Jan 24, 2022	SELL	$292.08 - $329.01 $1.56 Million - $1.75 Million	-5,328 Reduced 6.22%	80,274 $26.4 Million
Q3 2021 Oct 19, 2021	BUY	$272.21 - $332.43 $55,803 - $68,148	205 Added 0.24%	85,602 $26.1 Million
Q2 2021 Jul 19, 2021	BUY	$225.08 - $271.69 $269,870 - $325,756	1,199 Added 1.42%	85,397 $22.9 Million
Q1 2021 Apr 20, 2021	BUY	$212.38 - $245.9 $52,457 - $60,737	247 Added 0.29%	84,198 $19 Million
Q4 2020 Jan 22, 2021	SELL	$212.5 - $245.46 $371,662 - $429,309	-1,749 Reduced 2.04%	83,951 $18.6 Million
Q3 2020 Oct 20, 2020	SELL	$177.16 - $215.33 $153,243 - $186,260	-865 Reduced 1.0%	85,700 $18.5 Million
Q2 2020 Jul 17, 2020	SELL	$128.7 - $176.83 $158,944 - $218,385	-1,235 Reduced 1.41%	86,565 $15.3 Million
Q1 2020 Apr 16, 2020	SELL	$121.39 - $169.05 $22,457 - $31,274	-185 Reduced 0.21%	87,800 $12.2 Million
Q4 2019 Jan 17, 2020	BUY	$133.47 - $153.48 $283,356 - $325,838	2,123 Added 2.47%	87,985 $13.5 Million
Q3 2019 Oct 22, 2019	BUY	$135.4 - $146.47 $50,098 - $54,193	370 Added 0.43%	85,862 $12.4 Million
Q2 2019 Jul 16, 2019	SELL	$124.88 - $143.73 $59,318 - $68,271	-475 Reduced 0.55%	85,492 $12.2 Million
Q1 2019 Apr 11, 2019	BUY	$97.62 - $132.29 $355,532 - $481,800	3,642 Added 4.42%	85,967 $11.3 Million
Q4 2018 Jan 17, 2019	BUY	$94.85 - $109.54 $186,380 - $215,246	1,965 Added 2.45%	82,325 $8.49 Million
Q3 2018 Oct 12, 2018	BUY	$98.13 - $108.9 $178,105 - $197,653	1,815 Added 2.31%	80,360 $8.73 Million
Q2 2018 Jul 16, 2018	BUY	$96.1 - $103.24 $288,780 - $310,236	3,005 Added 3.98%	78,545 $7.75 Million
Q1 2018 Apr 11, 2018	SELL	$92.16 - $103.8 $557,107 - $627,471	-6,045 Reduced 7.41%	75,540 $7.4 Million
Q4 2017 Jan 16, 2018	BUY	$85.26 - $94.62 $249,385 - $276,763	2,925 Added 3.72%	81,585 $7.57 Million
Q3 2017 Oct 17, 2017	BUY	$79.29 - $88.45 $6.24 Million - $6.96 Million	78,660	78,660 $6.75 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Danaher Corp Transaction History